Clinical Impact of Functional CYP2C19 and CYP2D6 Gene Variants on Treatment with Antidepressants in Young People with Depression: A Danish Cohort Study

Clinical Impact of Functional CYP2C19 and CYP2D6 Gene Variants on Treatment with Antidepressants in Young People with Depression: A Danish Cohort Study

Background: The clinical impact of the functional CYP2C19 and CYP2D6 gene variants on antidepressant treatment in people with depression is not well studied. Here, we evaluate the utility of pharmacogenetic (PGx) testing in psychiatry by investigating the association between the phenotype status of...

Full description

Bibliographic Details
Main Authors: Liv S. Thiele, Kazi Ishtiak-Ahmed, Janne P. Thirstrup, Esben Agerbo, Carin A. T. C. Lunenburg, Daniel J. Müller, Christiane Gasse
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Pharmaceuticals
Subjects:
pharmacogenetics
antidepressants
utility
population-based
Online Access:https://www.mdpi.com/1424-8247/15/7/870

Internet

https://www.mdpi.com/1424-8247/15/7/870

Similar Items